Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1092654

registered interest
date	21/03/2019
answering body	Department for Digital, Culture, Media and Sport
answering dept id	10
answering dept short name	Digital, Culture, Media and Sport
answering dept sort name	Digital, Culture, Media and Sport
hansard heading	Voluntary Work: Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Digital, Culture, Media and Sport, what the source of funding is for the £10 million brand refresh for the National Citizen Service; and whether he can confirm that no government funding will be spent on this contract.
tabling member constituency	Lancaster and Fleetwood
tabling member printed	Cat Smith
uin	235376
answer	answer is ministerial correction date of answer 26/03/2019 answer text <p>To date, over 500,000 young people have taken part in the NCS programme. The most recently published evaluation has found that 82% of young people felt more positive about people from different backgrounds, and participants are more likely to use their time to help others after NCS<sup><sup>[1]</sup></sup>. Marketing is a key recruitment driver for NCS, ensuring that more young people across the country benefit from the programme.</p><p> </p><p>The brand refresh is one part of the overall marketing and creative services tender which includes communications planning, creative strategy, brand platform, experience, advertising campaign development, and content production. The £10m figure was stated in a NCS Trust procurement document as an upper limit over 4 years. The actual cost of the contract is likely to be around £1m per year, for 4 years of the contract.</p><p> </p><p>The NCS Trust is forecast to self-generate c. £3m income in the upcoming financial year. The brand refresh element of the marketing and creative services contract in question will be paid from those funds and we can confirm that no government funding will be spent on this element of the contract. The remainder of the contract will be funded by Government funding.</p><p> </p><p><sup><sup>[1]</sup></sup> This figure is based on the 2016 programme evaluation, which can be found <a href="https://www.gov.uk/government/publications/national-citizen-service-evaluation-report-2016" target="_blank">here</a>. The 2017 evaluation report is currently being finalised.</p><p> </p> answering member constituency Eastleigh answering member printed Mims Davies question first answered 26/03/2019 13:42:17 answering member 4513 label Biography information for Mims Davies
tabling member	4436 label Biography information for Cat Smith

1092655

registered interest
date	21/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Safety
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to manage risks to safety in compounding facilities in (a) NHS organisations and (b) commercial aseptic pharmacies.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	235304
answer	answer is ministerial correction date of answer 28/03/2019 answer text <p>Hospital pharmacy aseptic services can be provided under either:</p><p>- a specific exemption for pharmacists within medicine legislation (derived from section 10 of the Medicines Act 1968); or</p><p>- a specials manufacturing licence from the Medicines and Healthcare products Regulatory Agency (MHRA).</p><p> </p><p>Either approach requires services to meet the standards set by the MHRA within nationally recognised Good Manufacturing Practice. Licensed facilities are inspected by the MHRA and section 10 facilities are audited by regional quality assurance specialists under an Executive Letter, describing the arrangements for auditing unlicensed National Health Service aseptic units. The outcomes and risk ratings are reviewed through the NHS England Specialist Pharmacy Service.</p><p> </p><p>Commercial aseptic pharmacies must hold a specials manufacturing licence from the MHRA to supply compounded aseptic products to the NHS. The MHRA has its own inspection team who visit and review licensed facilities including both NHS and commercial. The MHRA has regulatory enforcement powers to close, restrict or require improvement in these licensed facilities.</p><p> </p><p>Capital spend to support individual pharmacy, aseptic or other NHS compounding services has historically been locally determined or has been part of wider whole hospital developments and, as such, there is no central repository of such spend.</p><p> </p><p>NHS Improvement has, through the initial work of reviewing NHS-provided aseptic services, identified a range of challenges linked to such services, including workforce. The next stage of this work will focus on workforce provision within the wider strategic review. This work does not include non-NHS organisations. Health Education England is undertaking a review that, linked with the NHS Improvement strategic service review, will identify the pharmacy technical services workforce issues across all grades and workforce groups.</p><p> </p><p>Aseptically compounded products are prepared from medicines that, in line with all medicines, are covered by the Department’s European Union exit planning process and products would all be included within the six-week additional stockpiling being managed through pharmaceutical suppliers.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 235305 235306 235307 question first answered 28/03/2019 16:18:41 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4382 label Biography information for Daniel Zeichner

1092656

registered interest
date	21/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Capital Investment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much capital funding has been spent on (a) pharmacy services, (b) aseptic pharmacy services and (c) compounding pharmacy services in each of the last five years.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	235305
answer	answer is ministerial correction date of answer 28/03/2019 answer text <p>Hospital pharmacy aseptic services can be provided under either:</p><p>- a specific exemption for pharmacists within medicine legislation (derived from section 10 of the Medicines Act 1968); or</p><p>- a specials manufacturing licence from the Medicines and Healthcare products Regulatory Agency (MHRA).</p><p> </p><p>Either approach requires services to meet the standards set by the MHRA within nationally recognised Good Manufacturing Practice. Licensed facilities are inspected by the MHRA and section 10 facilities are audited by regional quality assurance specialists under an Executive Letter, describing the arrangements for auditing unlicensed National Health Service aseptic units. The outcomes and risk ratings are reviewed through the NHS England Specialist Pharmacy Service.</p><p> </p><p>Commercial aseptic pharmacies must hold a specials manufacturing licence from the MHRA to supply compounded aseptic products to the NHS. The MHRA has its own inspection team who visit and review licensed facilities including both NHS and commercial. The MHRA has regulatory enforcement powers to close, restrict or require improvement in these licensed facilities.</p><p> </p><p>Capital spend to support individual pharmacy, aseptic or other NHS compounding services has historically been locally determined or has been part of wider whole hospital developments and, as such, there is no central repository of such spend.</p><p> </p><p>NHS Improvement has, through the initial work of reviewing NHS-provided aseptic services, identified a range of challenges linked to such services, including workforce. The next stage of this work will focus on workforce provision within the wider strategic review. This work does not include non-NHS organisations. Health Education England is undertaking a review that, linked with the NHS Improvement strategic service review, will identify the pharmacy technical services workforce issues across all grades and workforce groups.</p><p> </p><p>Aseptically compounded products are prepared from medicines that, in line with all medicines, are covered by the Department’s European Union exit planning process and products would all be included within the six-week additional stockpiling being managed through pharmaceutical suppliers.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 235304 235306 235307 question first answered 28/03/2019 16:18:41 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4382 label Biography information for Daniel Zeichner

1092657

registered interest
date	21/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Staff
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of workforce pressures in compounding pharmacies operated by (a) NHS organisations and (b) non-NHS organisations; and whether the pharmacy workforce will be included in the forthcoming NHS workforce plan.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	235306
answer	answer is ministerial correction date of answer 28/03/2019 answer text <p>Hospital pharmacy aseptic services can be provided under either:</p><p>- a specific exemption for pharmacists within medicine legislation (derived from section 10 of the Medicines Act 1968); or</p><p>- a specials manufacturing licence from the Medicines and Healthcare products Regulatory Agency (MHRA).</p><p> </p><p>Either approach requires services to meet the standards set by the MHRA within nationally recognised Good Manufacturing Practice. Licensed facilities are inspected by the MHRA and section 10 facilities are audited by regional quality assurance specialists under an Executive Letter, describing the arrangements for auditing unlicensed National Health Service aseptic units. The outcomes and risk ratings are reviewed through the NHS England Specialist Pharmacy Service.</p><p> </p><p>Commercial aseptic pharmacies must hold a specials manufacturing licence from the MHRA to supply compounded aseptic products to the NHS. The MHRA has its own inspection team who visit and review licensed facilities including both NHS and commercial. The MHRA has regulatory enforcement powers to close, restrict or require improvement in these licensed facilities.</p><p> </p><p>Capital spend to support individual pharmacy, aseptic or other NHS compounding services has historically been locally determined or has been part of wider whole hospital developments and, as such, there is no central repository of such spend.</p><p> </p><p>NHS Improvement has, through the initial work of reviewing NHS-provided aseptic services, identified a range of challenges linked to such services, including workforce. The next stage of this work will focus on workforce provision within the wider strategic review. This work does not include non-NHS organisations. Health Education England is undertaking a review that, linked with the NHS Improvement strategic service review, will identify the pharmacy technical services workforce issues across all grades and workforce groups.</p><p> </p><p>Aseptically compounded products are prepared from medicines that, in line with all medicines, are covered by the Department’s European Union exit planning process and products would all be included within the six-week additional stockpiling being managed through pharmaceutical suppliers.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 235304 235305 235307 question first answered 28/03/2019 16:18:41 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4382 label Biography information for Daniel Zeichner

1092658

registered interest
date	21/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect on aseptic compounding pharmacies operated by (a) NHS organisations and (b) non-NHS organisations of the UK leaving the EU without a deal.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	235307
answer	answer is ministerial correction date of answer 28/03/2019 answer text <p>Hospital pharmacy aseptic services can be provided under either:</p><p>- a specific exemption for pharmacists within medicine legislation (derived from section 10 of the Medicines Act 1968); or</p><p>- a specials manufacturing licence from the Medicines and Healthcare products Regulatory Agency (MHRA).</p><p> </p><p>Either approach requires services to meet the standards set by the MHRA within nationally recognised Good Manufacturing Practice. Licensed facilities are inspected by the MHRA and section 10 facilities are audited by regional quality assurance specialists under an Executive Letter, describing the arrangements for auditing unlicensed National Health Service aseptic units. The outcomes and risk ratings are reviewed through the NHS England Specialist Pharmacy Service.</p><p> </p><p>Commercial aseptic pharmacies must hold a specials manufacturing licence from the MHRA to supply compounded aseptic products to the NHS. The MHRA has its own inspection team who visit and review licensed facilities including both NHS and commercial. The MHRA has regulatory enforcement powers to close, restrict or require improvement in these licensed facilities.</p><p> </p><p>Capital spend to support individual pharmacy, aseptic or other NHS compounding services has historically been locally determined or has been part of wider whole hospital developments and, as such, there is no central repository of such spend.</p><p> </p><p>NHS Improvement has, through the initial work of reviewing NHS-provided aseptic services, identified a range of challenges linked to such services, including workforce. The next stage of this work will focus on workforce provision within the wider strategic review. This work does not include non-NHS organisations. Health Education England is undertaking a review that, linked with the NHS Improvement strategic service review, will identify the pharmacy technical services workforce issues across all grades and workforce groups.</p><p> </p><p>Aseptically compounded products are prepared from medicines that, in line with all medicines, are covered by the Department’s European Union exit planning process and products would all be included within the six-week additional stockpiling being managed through pharmaceutical suppliers.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 235304 235305 235306 question first answered 28/03/2019 16:18:41 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4382 label Biography information for Daniel Zeichner

1092659

registered interest
date	21/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antibiotics: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Tackling antimicrobial resistance 2019–2024: The UK’s five-year national action plan, published on 24 January 2019, what plans he has to fund the (a) design and (b) testing of a new economic model for antibiotics.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	235308
answer	answer is ministerial correction date of answer 29/03/2019 answer text <p>The project to develop and test the feasibility of new models that pay companies for antimicrobials based primarily on a heath technology assessment of their value to the National Health Service as opposed to the volumes used, and to share the learning with international stakeholders, is expected to be established by July this year.</p><p> </p><p>The NHS Long Term Plan, published in January this year, makes the commitment to implement the human health aspects of ‘Tackling Antimicrobial Resistance (2019-2024): the UK’s five-year national action plan’. The project will be led by a central project team resourced by the National Institute for Health and Care Excellence and NHS England and the National Institute for Health Research Policy Research Programme is considering research to support the process.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 29/03/2019 14:35:37 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4382 label Biography information for Daniel Zeichner

1092660

registered interest
date	21/03/2019
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Cycling and Walking
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Transport, what discussions he has had with the Local Government Association on encouraging councils to use City Region Deals to increase access to cycling and walking routes.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	235309
answer	answer is ministerial correction date of answer 25/03/2019 answer text <p>The Department made clear, in its 2018 response to the Cycling and Walking Investment Strategy Safety Review, that local councils should invest around 15 per cent of their local transport infrastructure funding on safe and efficient cycling and walking infrastructure. The Department continues to encourage local authorities to make use of the Transforming Cities Fund and other relevant national funding streams to support cycling and walking schemes and engages regularly with them in the development of their LCWIPs (Local Cycling and Walking Infrastructure Plans). Departmental officials have had discussions from time to time with representatives from the Local Government Association to discuss local authorities’ support for cycling and walking.</p><p> </p> answering member constituency Hereford and South Herefordshire answering member printed Jesse Norman question first answered 25/03/2019 15:57:25 answering member 3991 label Biography information for Jesse Norman
tabling member	4131 label Biography information for Jim Shannon

1092661

registered interest
date	21/03/2019
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Bus Services: Rural Areas
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Transport, what steps he is taking to secure less profitable rural bus routes and prevent an increase in rural isolation.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	235310
answer	answer is ministerial correction date of answer 29/03/2019 answer text <p>The Government recognises the importance of public transport in reducing social isolation, particularly in rural areas. Where there is not enough demand for a bus route to be commercially viable, all local authorities in England have powers to subsidise bus services. The Department provides £43 million per year to local authorities to support this. As part of the 2018-19 local government finance settlement, the Ministry of Housing, Communities and Local Government responded to a number of councils’ concerns over rural services funding by increasing the Rural Services Delivery Grant to £81 million. The 2019-20 settlement increased the Grant to the same level. This recognises the extra costs of providing services in rural communities. It is up to local government officials to decide how this funding is distributed.</p><p><strong> </strong></p> answering member constituency Wealden answering member printed Ms Nusrat Ghani question first answered 29/03/2019 13:42:34 answering member 4460 label Biography information for Ms Nusrat Ghani
tabling member	4131 label Biography information for Jim Shannon

1092662

registered interest
date	21/03/2019
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Air Routes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Transport, what steps he is taking to increase the number of global routes to smaller airports in Belfast and Cardiff and other essential hubs.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	235311
answer	answer is ministerial correction date of answer 26/03/2019 answer text <p>The Government is supportive of all airports, including Belfast and Cardiff, in creating new international connections. The Government believes that air passengers are best served by a competitive commercial airline market. It is for airlines to determine which airports they operate, based on their own assessment of costs and passenger demand.</p> answering member constituency Hereford and South Herefordshire answering member printed Jesse Norman question first answered 26/03/2019 16:43:10 answering member 3991 label Biography information for Jesse Norman
tabling member	4131 label Biography information for Jim Shannon

1092663

registered interest
date	21/03/2019
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Taxation: Bermuda
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, what representations his Department has made to the EU on behalf of Bermuda on its inclusion on the EU list of non-cooperative jurisdictions for tax purposes.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	235377
answer	answer is ministerial correction date of answer 26/03/2019 answer text <p>The UK has engaged with a wide range of stakeholders, including all EU Member States and many of the jurisdictions being assessed, as part of the process for agreeing the EU list of non-cooperative jurisdictions for tax purposes.</p><p> </p><p>Bermuda is a fiscally sovereign jurisdiction, and has been liaising directly with the EU institutions on this issue.</p><p> </p><p>The UK supports the list and has been active in discussions, ensuring the process is fair an objective across all jurisdictions.</p> answering member constituency Central Devon answering member printed Mel Stride question first answered 26/03/2019 13:48:00 answering member 3935 label Biography information for Mel Stride
tabling member	4657 label Biography information for Anneliese Dodds